These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
281 related articles for article (PubMed ID: 22785485)
1. Asymmetric dimethylarginine, an endogenous NOS inhibitor, is actively metabolized in rat erythrocytes. Yokoro M; Suzuki M; Murota K; Otsuka C; Yamashita H; Takahashi Y; Tsuji H; Kimoto M Biosci Biotechnol Biochem; 2012; 76(7):1334-42. PubMed ID: 22785485 [TBL] [Abstract][Full Text] [Related]
2. Gene transfer of dimethylarginine dimethylaminohydrolase-2 improves the impairments of DDAH/ADMA/NOS/NO pathway in endothelial cells induced by lysophosphatidylcholine. Feng M; Liu L; Guo Z; Xiong Y Eur J Pharmacol; 2008 Apr; 584(1):49-56. PubMed ID: 18342305 [TBL] [Abstract][Full Text] [Related]
3. Increased symmetrical dimethylarginine in ischemic acute kidney injury as a causative factor of renal L-arginine deficiency. Betz B; Möller-Ehrlich K; Kress T; Kniepert J; Schwedhelm E; Böger RH; Wanner C; Sauvant C; Schneider R Transl Res; 2013 Aug; 162(2):67-76. PubMed ID: 23707198 [TBL] [Abstract][Full Text] [Related]
4. Probucol decreases asymmetrical dimethylarginine level by alternation of protein arginine methyltransferase I and dimethylarginine dimethylaminohydrolase activity. Jiang JL; Zhang XH; Li NS; Rang WQ; Feng-Ye ; Hu CP; Li YJ; Deng HW Cardiovasc Drugs Ther; 2006 Aug; 20(4):281-94. PubMed ID: 16897158 [TBL] [Abstract][Full Text] [Related]
6. Molecular mechanism for elevation of asymmetric dimethylarginine and its role for hypertension in chronic kidney disease. Matsuguma K; Ueda S; Yamagishi S; Matsumoto Y; Kaneyuki U; Shibata R; Fujimura T; Matsuoka H; Kimoto M; Kato S; Imaizumi T; Okuda S J Am Soc Nephrol; 2006 Aug; 17(8):2176-83. PubMed ID: 16807406 [TBL] [Abstract][Full Text] [Related]
7. Pharmacotherapies and their influence on asymmetric dimethylargine (ADMA). Maas R Vasc Med; 2005 Jul; 10 Suppl 1():S49-57. PubMed ID: 16444869 [TBL] [Abstract][Full Text] [Related]
8. The prominent role of the liver in the elimination of asymmetric dimethylarginine (ADMA) and the consequences of impaired hepatic function. Richir MC; Bouwman RH; Teerlink T; Siroen MP; de Vries TP; van Leeuwen PA JPEN J Parenter Enteral Nutr; 2008; 32(6):613-21. PubMed ID: 18974239 [TBL] [Abstract][Full Text] [Related]
9. Ammonia Reduces Intracellular Asymmetric Dimethylarginine in Cultured Astrocytes Stimulating Its y⁺LAT2 Carrier-Mediated Loss. Milewski K; Bogacińska-Karaś M; Fręśko I; Hilgier W; Jaźwiec R; Albrecht J; Zielińska M Int J Mol Sci; 2017 Nov; 18(11):. PubMed ID: 29099056 [TBL] [Abstract][Full Text] [Related]
10. Regulation of cytokine-induced nitric oxide synthesis by asymmetric dimethylarginine: role of dimethylarginine dimethylaminohydrolase. Ueda S; Kato S; Matsuoka H; Kimoto M; Okuda S; Morimatsu M; Imaizumi T Circ Res; 2003 Feb; 92(2):226-33. PubMed ID: 12574151 [TBL] [Abstract][Full Text] [Related]
12. Lysophosphatidylcholine-induced elevation of asymmetric dimethylarginine level by the NADPH oxidase pathway in endothelial cells. Jia SJ; Jiang DJ; Hu CP; Zhang XH; Deng HW; Li YJ Vascul Pharmacol; 2006 Mar; 44(3):143-8. PubMed ID: 16309971 [TBL] [Abstract][Full Text] [Related]
13. Evidence for dysregulation of dimethylarginine dimethylaminohydrolase I in chronic hypoxia-induced pulmonary hypertension. Millatt LJ; Whitley GS; Li D; Leiper JM; Siragy HM; Carey RM; Johns RA Circulation; 2003 Sep; 108(12):1493-8. PubMed ID: 12952847 [TBL] [Abstract][Full Text] [Related]
14. The ADMA/DDAH/NO pathway in human vein endothelial cells exposed to arsenite. Osorio-Yáñez C; Chin-Chan M; Sánchez-Peña LC; Atzatzi-Aguilar OG; Olivares-Reyes JA; Segovia J; Del Razo LM Toxicol In Vitro; 2017 Aug; 42():281-286. PubMed ID: 28502835 [TBL] [Abstract][Full Text] [Related]
15. Impact of high salt independent of blood pressure on PRMT/ADMA/DDAH pathway in the aorta of Dahl salt-sensitive rats. Cao Y; Mu JJ; Fang Y; Yuan ZY; Liu FQ Int J Mol Sci; 2013 Apr; 14(4):8062-72. PubMed ID: 23584024 [TBL] [Abstract][Full Text] [Related]
16. Nitric oxide upregulates dimethylarginine dimethylaminohydrolase-2 via cyclic GMP induction in endothelial cells. Sakurada M; Shichiri M; Imamura M; Azuma H; Hirata Y Hypertension; 2008 Nov; 52(5):903-9. PubMed ID: 18824664 [TBL] [Abstract][Full Text] [Related]
17. Asymmetric dimethylarginine (ADMA), symmetric dimethylarginine (SDMA) and homoarginine (hArg): the ADMA, SDMA and hArg paradoxes. Tsikas D; Bollenbach A; Hanff E; Kayacelebi AA Cardiovasc Diabetol; 2018 Jan; 17(1):1. PubMed ID: 29301528 [TBL] [Abstract][Full Text] [Related]
18. The enzymatic machinery for ADMA synthesis and degradation is fully expressed in human adipocytes. Spoto B; Parlongo RM; Parlongo G; Sgro' E; Zoccali C J Nephrol; 2007; 20(5):554-9. PubMed ID: 17918140 [TBL] [Abstract][Full Text] [Related]
19. Role of dimethylarginine dimethylaminohydrolases in the regulation of endothelial nitric oxide production. Pope AJ; Karrupiah K; Kearns PN; Xia Y; Cardounel AJ J Biol Chem; 2009 Dec; 284(51):35338-47. PubMed ID: 19820234 [TBL] [Abstract][Full Text] [Related]
20. The effect of nebivolol on asymmetric dimethylarginine system in spontaneously hypertension rats. Wang Y; Zhang M; Liu Y; Liu Y; Chen M Vascul Pharmacol; 2011; 54(1-2):36-43. PubMed ID: 21167314 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]